David H. Kirske
2018
In 2018, David H. Kirske earned a total compensation of $883.7K as Executive Vice President, Chief Financial Officer at CTI BioPharma, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $122,500 |
|---|---|
| Option Awards | $402,980 |
| Salary | $350,000 |
| Other | $8,250 |
| Total | $883,730 |
Kirske received $403K in option awards, accounting for 46% of the total pay in 2018.
Kirske also received $122.5K in non-equity incentive plan, $350K in salary and $8.3K in other compensation.
Rankings
In 2018, David H. Kirske's compensation ranked 9,763rd out of 14,244 executives tracked by ExecPay. In other words, Kirske earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,763 out of 14,244 | 32nd |
Division Manufacturing | 3,939 out of 5,765 | 32nd |
Major group Chemicals And Allied Products | 1,479 out of 2,128 | 31st |
Industry group Drugs | 1,246 out of 1,817 | 31st |
Industry Pharmaceutical Preparations | 958 out of 1,391 | 31st |
Source: SEC filing on April 4, 2019.
Kirske's colleagues
We found three more compensation records of executives who worked with David H. Kirske at CTI BioPharma in 2018.